InvestorsHub Logo
Followers 60
Posts 7866
Boards Moderated 0
Alias Born 05/18/2007

Re: powerwalker post# 377849

Saturday, 10/15/2022 10:31:23 AM

Saturday, October 15, 2022 10:31:23 AM

Post# of 473090
Anavex will be presenting TLD from its P2b/3 trial of blarcamesine's impact on Alzheimer's Disease on December 1st @ the CTAD in San Francisco. We believe the data is very compelling and are in talks with the fda as to our company's next steps."

Without releasing the data can he say to the world that the data is very compelling ? Not sure about that.


Yeah the part - 'in talks with the fda as to our company's next steps. has some positive intent/vibes. May be he could use 'excited' in the sentence to convey the message
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News